Evidence map›Paper›PMID 21764293›Full record

ReviewCurrent opinion in genetics & development2011

Defects in translational regulation contributing to human cognitive and behavioral disease.

J C Darnell

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in genetics & development, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. The fragile X proteins' enigma: to be or not to be nucleolar.Frontiers in cell and developmental biology · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Regulatory BC1 RNA in cognitive control.Learning & memory (Cold Spring Harbor, N.Y.) · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2015
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

J C DarnellDepartment of Molecular Neuro-Oncology, The Rockefeller University, 1230 York Ave., New York, NY 10065, USA. darneje@rockefeller.edu
Rockefeller University · US

Funding

IDENTIFICATION OF FMRP TARGET RNASR01HD040647 · NICHD · ROCKEFELLER UNIVERSITY · PI DARNELL, JENNIFER C · 2001 to 2017
$4.5M
NICHD NIH HHS R01 HD040647NICHD NIH HHS R01 HD40647
6 · The paper itself

Abstract

Recent data suggest that the levels of many synaptic proteins may be tightly controlled by the opposing processes of new translation and protein turnover in neurons. Alterations in this balance or in the levels of such dosage-sensitive proteins that result in altered stoichiometry of protein complexes at developing and remodeling synapses may underlie several human cognitive diseases including Fragile X Syndrome, autism spectrum disorders, Angelman syndrome and non-syndromic mental retardation. While a significant amount is known about the transduction of membrane signals to the translational apparatus through kinase cascades acting on general translation factors, much less is understood about how such signals may influence the activity of mRNA-specific regulators, their mechanisms of action and the specific sets of mRNAs they regulate. New approaches to the unbiased in vivo identification of maps of binding sites for these proteins on mRNA is expected to greatly increase our understanding of this crucial level of regulation in neuronal development and function.

Indexed as

Protein BiosynthesisBehavioral SymptomsCognition DisordersGene Expression RegulationHumansSynapsesSynaptic Transmission

Identifiers

PMID21764293
PMCPMC3166213
OpenAlexW2094646458

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.